BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

SAMORITA

All Eps Dividend Board Agm Q1 Q2 Q3

SAMORITA 31-Oct-2021

(Continuation news of SAMORITA): Reason for significant deviation: Operating result in the reporting period has been significantly increased due to the following reasons, compared to previous corresponding period: i) Revenue has been increased by Tk. 2.69 crore for treatment of more covid patients. ii) Cost of direct materials has been decreased from 42.92% to 39.49%. (cont. 2)

SAMORITA 31-Oct-2021

(Q1 Un-audited): EPS was Tk. 1.08 for July-September 2021 as against Tk. 0.34 for July-September 2020; NOCFPS was Tk. 1.57 for July-September 2021 as against Tk. 1.01 for July-September 2020. NAV per share was Tk. 52.54 as on September 30, 2021 and Tk. 51.46 as on June 30, 2021. (cont. 1)

SAMORITA 31-Oct-2021

There will be no price limit on the trading of the shares of the Company on today (31.10.2021) for following its corporate declaration.

SAMORITA 31-Oct-2021

(Continuation news of SAMORITA): Date of EGM & AGM: 29.12.2021, Time of EGM and AGM: 11:00 AM and 11:30 AM respectively, Venue: Digital Platform. Record Date for EGM & AGM: 23.11.2021. The Company has reported EPS of Tk. 2.23, NAV per share of Tk. 51.46 and NOCFPS of Tk. 3.18 for the year ended on June 30, 2021 as against Tk. 0.17, Tk. 49.23 and Tk. 0.64 respectively for the same period of the previous year. (end)

SAMORITA 31-Oct-2021

The Board of Directors has recommended 10% cash dividend for the year ended on June 30, 2021. The Board of Directors has also decided in the said meeting to increase the Authorized Share Capital of the company from Tk. 20.00 crore to Tk. 50.00 crore by amending the Clause-V of the Memorandum of Association and Article- 5 of the Articles of Association of the Company, subject to the approval of the shareholders in the 3rd Extra ordinary General Meeting (EGM) of the company as special Resolution. (cont.)

SAMORITA 19-Oct-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 30, 2021 at 11:00 AM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.

SAMORITA 19-Oct-2021

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 30, 2021 at 11:00 AM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.

SAMORITA 25-Jul-2021

(cont. of SAMORITA): The entire amount will be financed from own source of the company. It was also decided in the meeting that two building purchased recently adjacent to hospital premises will be let-out for residential purpose after some renovation works until any other decision is taken. The estimated renovation cost will be BDT 40,00,000.00 and estimated monthly rent of BDT. 1,70,000.00. (end)

SAMORITA 25-Jul-2021

The Company has informed that the Board of Directors has approved the proposal to construct 08 storied building including basement measuring a total of 15,560 sq. feet (appx.) in the land adjacent to hospital premises. The building space will be used for ETP, Physiotherapy center, Chemotherapy unit, Consultants chamber, Canteen and Dormitory purposes. Estimated total cost of the project will be BDT. 5,50,00,000.00 and the project will be completed by the year 2023. (cont.)

SAMORITA 28-Apr-2021

(Q3 Un-audited): EPS was Tk. 0.23 for January-March 2021 as against Tk. 0.12 for January-March 2020; EPS was Tk. 1.58 for July 2020-March 2021 as against Tk. 1.19 for July 2019-March 2020. NOCFPS was Tk. 2.88 for July 2020-March 2021 as against Tk. 1.79 for July 2019-March 2020. NAV per share was Tk. 50.81 as on March 31, 2021 and Tk. 49.23 as on June 30, 2020.

Previous Next page